F418-0251 Screening compound: 3-[3-(2,3-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-1,4-dihydroquinolin-4-one

F418-0251 Screening compound: 3-[3-(2,3-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-1,4-dihydroquinolin-4-one
F418-0251 Screening compound: 3-[3-(2,3-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-1,4-dihydroquinolin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound F418-0251
3-[3-(2,3-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-1,4-dihydroquinolin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F418-0251

Molecular Formula

C25H25FN4O5 (C25 H25 FN4 O5)

Compound Name

3-[3-(2,3-dimethoxyphenyl)-1,2,4-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-1,4-dihydroquinolin-4-one

IUPAC name

3-[3-(23-dimethoxyphenyl)-124-oxadiazol-5-yl]-1-ethyl-6-fluoro-7-(morpholin-4-yl)-14-dihydroquinolin-4-one

SMILES

CCN(C=C(c1nc(-c(cccc2OC)c2OC)no1)C(c1c2)=O)c1cc(N1CCOCC1)c2F

InChI

InChI=1S/C25H25FN4O5/c1-4-29-14-17(25-27-24(28-35-25)15-6-5-7-21(32-2)23(15)33-3)22(31)16-12-18(26)20(13-19(16)29)30-8-10-34-11-9-30/h5-7,12-14H,4,8-11H2,1-3H3

InChI Key

GVORRFXXFYDCLM-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD22589385

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

480.5

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.147

Distribution Coefficient, logD

3.147

Water Solubility, LogSw

-3.44

Polar Surface Area

73.372

Acid Dissociation Constant (pKa)

28.26

Base Dissociation Constant (pKb)

-0.36

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.00

F418-0251 in Drug Discovery

Included in Screening Libraries

PI3K-Targeted Library (17255 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F418-0251 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F418-0251?
Check Price and Availability of F418-0251, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F418-0251 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F418-0251
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F418-0251
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F418-0251 available by request